Brief: Zydus Lifesciences Says Sentynl Therapeutics Enters Into Agreement With PRG S&T
March 16 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS: ZYDUS LIFESCIENCES - SENTYNL THERAPEUTICS ENTERS INTO AGREEMENT WITH PRG S&T ZYDUS LIFESCIENCES - AGREEMENT TO LICENSE MOLECULE FOR HUTCHINSONGILFORD PROGERIA SYNDROME Further company coverage: ZYDU.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Zydus Lifesciences
See all newsIndia's Zydus Lifesciences posts lower profit as expenses outpace revenue growth
Brief: Zydus Lifesciences Q2 Consol Net Profit 9.26 Billion Rupees
Brief: Zydus Lifesciences Says Zylidac Bio And Prolific Machines Partner
Brief: Zydus Lifesciences Receives U.S. FDA Approval For Estradiol And Levonorgestrel Transdermal System
Brief: Zydus Lifesciences Says Zydus Sunshine Lifesciences Signs Agreement To Establish A Pharmaceutical Manufacturing Facility In Sri Lanka